Regeneron Pharmaceuticals Operating Expenses 2010-2024 | REGN
Regeneron Pharmaceuticals operating expenses for the twelve months ending September 30, 2024 were $9.874B, a 11.24% increase year-over-year.
- Regeneron Pharmaceuticals annual operating expenses for 2023 were $9.07B, a 22.01% increase from 2022.
- Regeneron Pharmaceuticals annual operating expenses for 2022 were $7.434B, a 4.34% increase from 2021.
- Regeneron Pharmaceuticals annual operating expenses for 2021 were $7.125B, a 44.8% increase from 2020.